Aileron Therapeutics
ALRN
$4.06
Share price
6.65%
Change (1 day)
198.90%
Change (1 year)
Categories
Aileron Therapeutics (ALRN) - P/B ratio
P/B ratio as of May 2024 : 9.41
According to Aileron Therapeutics
's latest financial reports the company has a price-to-book ratio of 9.41.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Aileron Therapeutics - P/B ratio (from 2017 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 2.16 | 274.22% |
| 2022-12-31 | 0.5779 | -50.23% |
| 2021-12-31 | 1.16 | -66.62% |
| 2020-12-31 | 3.48 | 250.36% |
| 2019-12-31 | 0.9930 | 57.1% |
| 2018-12-31 | 0.6321 | -80.53% |
| 2017-12-31 | 3.25 | |
| 2016-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | 2.86 | -69.57% | 🇺🇸 USA |